Drugmakers — major beneficiaries of NIH-backed university research — have been largely silence on the Trump administration's ...

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

Robert F. Kennedy Jr. was confirmed by the Senate on Thursday as the next Secretary of Health and Human Services despite the ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

The impact will be crippling to biomedical research in the U.S., and institutions will immediately face hard choices about ...

Robert F. Kennedy Jr. (RFK Jr.) has been confirmed by the Senate as secretary of the Department of Health and Human Services (HHS). In this ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in financial support could also lead to the loss of critical data if research teams ...

US President Donald Trump kicked off his second term with a series of directives aimed at the US National Institutes of ...

In this week's InnovationRx newsletter, federal judges halt Trump's cuts to NIH research payments, rural hospitals' ongoing ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

The phase 2 CAFETERIA study included participants aged 4 to 14 years who were able to tolerate at least 143mg of peanut protein.